CClinicalTrials.gg
CompletedNCT03083457PEEP-RMUpdated Jan 29, 2021

Physiological Effects of Lung Recruitment During General Anesthesia and Low-tidal Volume Ventilation

An interventional study of Fluid resuscitation or amine administration and General anesthetic in Anesthesia, General and Surgery, sponsored by Catholic University of the Sacred Heart. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-29.

Sponsored by Catholic University of the Sacred Heart · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Low-tidal volume ventilation is arising as a tool to optimize the ventilatory management and to improve clinical outcome in patients undergoing general anesthesia for abdominal surgery.

A recent large randomized controlled trial failed to detect a significant difference between two different approaches for ensuring adequate lung recruitment (PEEP=12 cmH2O + scheduled recruiting maneuvers vs. PEEP 2 cmH2O) during protective ventilation. Thus, in patients undergoing open abdominal surgery and receiving low-tidal volumes, the effects of different positive end-expiratory pressure (PEEP) levels and recruiting maneuvers remain to be established.

Design: prospective, cross-over, physiological trial.

PURPOSE To assess the physiological effects of different PEEP levels with or without scheduled recruiting maneuvers in patients undergoing general anesthesia for open abdominal surgery and receiving low-tidal volume ventilation.

02

Conditions studied

  • Anesthesia, General
  • Surgery
03

In context

Lead sponsor

Catholic University of the Sacred Heart is the lead sponsor of 227 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ASA physical status I-II patients
  • scheduled for open abdominal surgery (major gastrointestinal surgery: duodeno-cephalo-pancreatectomy, gastrectomy, hemi-colectomy; gynecological surgery; oncologic surgery)
  • Expected duration of surgery >= 150 minutes

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • BMI>30 kg/m\^2
  • hepatic surgery
  • Cardiac failure NYHA>2
  • History of chronic respiratory failure
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    PEEP2 + RM

    General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=2 cmH2O and scheduled recruiting maneuvers at the beginning of each PEEP step, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

    Drug: Fluid resuscitation or amine administration · Drug: General anesthetic · Drug: Fluid administration · Procedure: Low-tidal volume ventilation · Procedure: Scheduled recruiting maneuvers

  • Experimental
    PEEP7 + RM

    General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=7 cmH2O and scheduled recruiting maneuvers at the beginning of the PEEP step, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

    Drug: Fluid resuscitation or amine administration · Drug: General anesthetic · Drug: Fluid administration · Procedure: Low-tidal volume ventilation · Procedure: Scheduled recruiting maneuvers

  • Experimental
    PEEP12 + RM

    General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=12 cmH2O and scheduled recruiting maneuvers at the beginning of the PEEP step, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

    Drug: Fluid resuscitation or amine administration · Drug: General anesthetic · Drug: Fluid administration · Procedure: Low-tidal volume ventilation · Procedure: Scheduled recruiting maneuvers

  • Experimental
    PEEP2 - RM

    General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=2 cmH2O, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

    Drug: Fluid resuscitation or amine administration · Drug: General anesthetic · Drug: Fluid administration · Procedure: Low-tidal volume ventilation

  • Experimental
    PEEP7 - RM

    General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=7 cmH2O, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

    Drug: Fluid resuscitation or amine administration · Drug: General anesthetic · Drug: Fluid administration · Procedure: Low-tidal volume ventilation

  • Experimental
    PEEP12 - RM.

    General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=12 cmH2O, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

    Drug: Fluid resuscitation or amine administration · Drug: General anesthetic · Drug: Fluid administration · Procedure: Low-tidal volume ventilation

Interventions

  • DrugFluid resuscitation or amine administration

    Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

  • DrugGeneral anesthetic

    Total intravenous anesthesia with a standard protocol

  • DrugFluid administration

    3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

  • ProcedureLow-tidal volume ventilation

    Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

  • ProcedureScheduled recruiting maneuvers

    Pressure-control ventilation inspiratory pressure=10 cmH2O. Steplike 5-cmH2O-PEEP increase every 30 seconds to achieve a peep of 35 cmH2O, followed by 5-cmH2O-PEEP reduction every 30 seconds to set PEEP

06

What researchers measure

Primary outcomes

  1. Driving Pressure

    Respiratory system elastic pressure (Plateau pressure-total PEEP)

    Time frame: At the end of each 40-minute step

Secondary outcomes

  1. Lung strain

    Lung static and dynamic strain

    Time frame: At the end of each 40-minute step

  2. Dead space

    Approximated as the difference between End-tidal CO2 and PaCO2 divided by PaCO2

    Time frame: At the end of each 40-minute step

  3. Oxygenation

    PaO2/FiO2

    Time frame: At the end of each 40-minute step

  4. Lung recruitment

    % (lung recruitment/change in end-expiratory lung volume)

    Time frame: At the end of each 40-minute step

  5. Lung overdistension due to PEEP

    % (lung overdistension/change in end-expiratory lung volume)

    Time frame: At the end of each 40-minute step

  6. Functional residual capacity

    Change in functional residual capacity due to PEEP, measured with the Nitrogen washin-washout technique

    Time frame: At the end of each 40-minute step

  7. Heart rate

    heart rate

    Time frame: At the end of each 40-minute step

  8. Blood pressure

    Arterial blood pressure

    Time frame: At the end of each 40-minute step

  9. Stroke volume

    Stroke volume, measured by pulse contour analysis

    Time frame: At the end of each 40-minute step

  10. Stroke volume variation

    Stroke volume variation, measured by pulse contour analysis

    Time frame: At the end of each 40-minute step

  11. Cardiac Output

    Stroke volume x heart rate

    Time frame: At the end of each 40-minute step

  12. Fluid requirements

    Fluid bolus requirements, according to the decision of the attending physician blinded to the design of the study

    Time frame: At the end of each 40-minute step

  13. Vasoactive agents

    Vasoactive agents requirements, according to the decision of the attending physician blinded to the design of the study

    Time frame: At the end of each 40-minute step

  14. Adverse events

    Adverse events

    Time frame: At the end of each 40-minute step

07

Study locations

1 site
  • General surgery OR, A. Gemelli hospital
    Rome, 00100, Italy
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03083457
Lead sponsor
Catholic University of the Sacred Heart
Responsible party
Massimo Antonelli (MD, Catholic University of the Sacred Heart) — Principal investigator
First posted
Mar 20, 2017
Start date
Mar 20, 2017
Primary completion
Nov 30, 2020
Completion
Nov 30, 2020
Last update
Jan 29, 2021

Study contacts

Massimo Antonelli, MD
principal investigator · Catholic University of the Sacred Heart

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion